Graymax Laboratories

Our Graymax Laboratories unit continues our growth as a key partner in the scientific community.

Exciting new technologies are emerging that have the potential to bring about treatments and cures to benefit our global community.

Discovery research is the early phase in the drug development process. Initial identification and validation of promising target molecules can lead the way to a better understanding of the mechanisms involved in those molecules, and possible success in the later stages of drug development.

Investor information: graymax@karlan.com